Resident Research |
|
Neurotrauma Recently endowed with significant funding from the Virginia Commonwealth Neurotrauma Initiative, the neurotrauma lab has gained national recognition in neurotrauma research. The primary research focus is on the role of apoptosis in primary and secondary injury. In addition, residents and researchers have pioneered quantitative analysis of traumatic neurologic injury using unique visualization techniques such as FRET. Spinal Fusion, Gene Therapy, and Molecular Genetics of Brain Tumors The laboratory of Dr. Gregory Helm has been studying the augmentation of spine fusion using bone morphogenetic protein (BMP), gene therapy with modified viral vectors, and analysis of brain tumors using new gene chip technology. Cerebrovascular Disease The cerebrovascular laboratory is actively studying the role of inflammation in cerebral vasospasm following subarachnoid hemorrhage and the augmentation of cerebral oxygenation following ischemic stroke Neuro-oncology The neuro-oncology laboratory, led by Drs. Mark Shaffrey and David Schiff, is involved in both clinical and basic science research of primary brain tumors. In addition to involvement in all major regional and national neuro-oncology group clinical trials, basic science research has recently focused on the role of neuropathological tumor characteristics in predicting outcome and recurrence. In addition, neuropsychological and patient satisfaction following resection of brain tumors is being studied. Other areas of research
|